Takeda Pharmaceuticals America Inc., headquartered in Cambridge, MA, appears in the available FY2024-FY2026 LCA dataset with 6 filing records, a limited sponsorship-filing pattern among U.S. employers tracked here. Takeda Pharmaceuticals America Inc. is also matched with 4 PERM filings in the available FY2024-FY2025 PERM dataset, a descriptive filing pattern rather than an individual green-card outcome. These are public LCA filings, not visa approvals, hires, or open roles, and the figures generally exclude equity, bonus, and benefits.
No elevated signal appears in the currently matched LCA and USCIS datasets. This is descriptive filing history, not immigration, legal, or employment advice.
Takeda Pharmaceuticals America Inc. has 6 H-1B LCA filing records in FY2024-FY2026.
The available filings do not provide enough complete wage observations for a peer comparison.
4 PERM filings are matched to this employer; this is not a green-card success rate.
Takeda Pharmaceuticals America Inc. shows limited H-1B LCA filing activity in the available FY2024-FY2026 dataset, with 6 public LCA records. The available profile does not expose enough role clusters for a richer role summary. Major worksite filing activity appears in Cambridge, MA, Lexington, MA, and Bannockburn, IL. These records are not final visa approvals, hires, or open roles.
The available LCA records do not provide enough complete wage observations for a median filed wage signal on this employer page.
Takeda Pharmaceuticals America Inc. has 4 matched PERM filings in the available FY2024-FY2025 dataset. The PERM-to-H-1B Filing Ratio is 67%, meaning PERM filings divided by H-1B LCA filings in the available public datasets; it is descriptive filing activity, not an individual green-card success rate.
Annual LCA filings across the available fiscal years.
Distribution is not available for this page because the source filings do not include enough complete salary observations.